4.4 Article

Proper understanding of recurrent stress urinary incontinence treatment in women (PURSUIT): a randomised controlled trial of endoscopic and surgical treatment

Journal

TRIALS
Volume 23, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13063-022-06546-9

Keywords

PURSUIT; Recurrent stress urinary incontinence; Endoscopic bulking injections; Surgery; Colposuspension; Autologous fascial sling; Artificial urinary sphincter; Randomised controlled trial; International Consultation on Incontinence Questionnaire; Urinary Incontinence; Short Form (ICIQ-UI-SF); Qualitative

Funding

  1. National Institute for Health and Care Research (NIHR), Health Technology Assessment (HTA) programme [17/95/03]
  2. National Institutes of Health Research (NIHR) [17/95/03] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

This study aims to compare the effectiveness of surgical treatment and endoscopic bulking injections in women with recurrent or persistent SUI. The primary outcome is symptom severity measured using the ICIQ-UI-SF questionnaire, and secondary outcomes include longer-term clinical impact, symptom improvement, safety, operative assessments, sexual function, cost-effectiveness, and evaluation of patient and clinician perspectives. This research is important for guiding further treatment and improving symptoms and quality of life for women with this condition.
Background Women with stress urinary incontinence (SUI) experience urine leakage with physical activity. Currently, the interventional treatments for SUI are surgical, or endoscopic bulking injection(s). However, these procedures are not always successful, and symptoms can persist or come back after treatment, categorised as recurrent SUI. There are longstanding symptoms and distress associated with a failed primary treatment, and currently, there is no consensus on how best to treat women with recurrent, or persistent, SUI. Methods A two-arm trial, set in at least 20 National Health Service (NHS) urology and urogynaecology referral units in the UK, randomising 250 adult women with recurrent or persistent SUI 1:1 to receive either an endoscopic intervention (endoscopic bulking injections) or a standard NHS surgical intervention, currently colposuspension, autologous fascial sling or artificial urinary sphincter. The aim of the trial is to determine whether surgical treatment is superior to endoscopic bulking injections in terms of symptom severity at 1 year after randomisation. This primary outcome will be measured using the patient-reported International Consultation on Incontinence Questionnaire - Urinary Incontinence - Short Form (ICIQ-UI-SF). Secondary outcomes include assessment of longer-term clinical impact, improvement of symptoms, safety, operative assessments, sexual function, cost-effectiveness and an evaluation of patients' and clinicians' views and experiences of the interventions. Discussion There is a lack of high-quality, randomised, scientific evidence for which treatment is best for women presenting with recurrent SUI. The PURSUIT study will benefit healthcare professionals and patients and provide robust evidence to guide further treatment and improve symptoms and quality of life for women with this condition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available